Primary tumour response in patients treated with nivolumab for metastatic renal cell carcinoma (mRCC): Results of the GETUG-AFU 26 NIVOREN trial

Affiliation auteursAffiliation ok
TitrePrimary tumour response in patients treated with nivolumab for metastatic renal cell carcinoma (mRCC): Results of the GETUG-AFU 26 NIVOREN trial
Type de publicationJournal Article
Year of Publication2020
AuteursCourcier J., Dalban C., Laguerre B., Ladoire S., Barthelemy P., Oudard S., Joly F., G. Mescam G, Chevreau C.M, Geoffrois L., Deluche E., Rolland F., Topart D., Culine S., Negrier S., Mahammedi H., Tantot F., Escudier B., Flippot R., Albiges L.
JournalANNALS OF ONCOLOGY
Volume31
PaginationS560
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN0923-7534